Ms Kirstie Mowat
- Research Nurse Manager (Cardiovascular & Metabolic Health)
The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Clarity helps us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
Campbell, R. T. et al. (2026) Early discharge strategy including subcutaneous furosemide in hospitalized heart failure. Journal of the American College of Cardiology, 88(15), pp. 1781-1793. (doi: 10.1016/j.jacc.2026.07.047) (PMID:42872757)
Campbell, R. T. et al. (2026) SUBCUT HF II: rationale and design of a multicentre randomized controlled trial of SUBCUTaneous furosemide to support early discharge in patients admitted to hospital due to Heart Failure. European Journal of Heart Failure, (doi: 10.1093/ejhf/xuaf018) (Early Online Publication)
Campbell, R. T. et al. (2026) Early discharge strategy including subcutaneous furosemide in hospitalized heart failure. Journal of the American College of Cardiology, 88(15), pp. 1781-1793. (doi: 10.1016/j.jacc.2026.07.047) (PMID:42872757)
Campbell, R. T. et al. (2026) SUBCUT HF II: rationale and design of a multicentre randomized controlled trial of SUBCUTaneous furosemide to support early discharge in patients admitted to hospital due to Heart Failure. European Journal of Heart Failure, (doi: 10.1093/ejhf/xuaf018) (Early Online Publication)